Ep. 205 Weight Loss Medications & Impact on OSA with Dr. John Carter and Dr. Michael Weber

How are weight loss medications, like Ozempic, reshaping obstructive sleep apnea care? In this episode of the BackTable ENT podcast, host Dr. Gopi Shah discusses emerging weight loss medications and their impact on obstructive sleep apnea (OSA) with Dr. John Carter, a neurologist and sleep specialist, and Dr. Michael Weber, an otolaryngologist. --- SYNPOSIS The doctors examine optimal candidates for GLP-1 medications, their side effects, and how these drugs integrate into current OSA treatment pathways. The conversation delves into patients’ experiences, new research findings, and the implications for future sleep apnea management and weight loss strategies. In sum, the episode highlights the promising role of GLP-1 medications while addressing potential challenges and unanswered questions. --- TIMESTAMPS 00:00 - Introduction 03:06 - Understanding Weight Loss Medications 06:18 - Impact of Weight Loss on OSA 12:56 - Clinical Trials and Research 18:57 - Future of OSA Management 23:19 - Challenges and Considerations 29:27 - Pediatric Considerations 37:05 - Final Thoughts and Contact Information --- RESOURCES Dr. John Carter Profile https://www.metrohealth.org/physician/john-carter-176808 Dr. Michael Weber https://www.metrohealth.org/physician/michael-weber-174663 BackTable+ for ENT https://plus.backtable.com/pages/ent Check out BackTable+ for ENT, our sponsor and new e-learning platform! https://plus.backtable.com/pages/ent

There are no comments yet.

Please log in to write the first comment.